Clinical Trials Browser

Recruiting × Seminoma × 90 days × Clear all

Carcinosarcoma, Glioma, Seminoma, Adenocarcinoma, Clear Cell, Carcinoma, Small Cell, Sex Cord-Gonadal Stromal Tumors, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

NCT06309745 2026-03-02

THERATEST

Recruiting

30 enrolled

Seminoma

NCT07218913 2026-01-26

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Phase 1 Recruiting

44 enrolled

Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

NCT05345158 2025-12-19

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma

Phase NA Recruiting

25 enrolled

Seminoma

Clinical Trials

SUR-CAN

THERATEST

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma